Interinstitutional analysis of the outcome after surgery for type A aortic dissection.


Journal

European journal of trauma and emergency surgery : official publication of the European Trauma Society
ISSN: 1863-9941
Titre abrégé: Eur J Trauma Emerg Surg
Pays: Germany
ID NLM: 101313350

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 24 11 2022
accepted: 10 02 2023
medline: 25 8 2023
pubmed: 25 2 2023
entrez: 24 2 2023
Statut: ppublish

Résumé

To evaluate the impact of individual institutions on the outcome after surgery for Stanford type A aortic dissection (TAAD). This is an observational, multicenter, retrospective cohort study including 3902 patients who underwent surgery for TAAD at 18 university and non-university hospitals. Logistic regression showed that four hospitals had increased risk of in-hospital mortality, while two hospitals were associated with decreased risk of in-hospital mortality. Risk-adjusted in-hospital mortality rates were lower in four hospitals and higher in other four hospitals compared to the overall in-hospital mortality rate (17.7%). Participating hospitals were classified as overperforming or underperforming if their risk-adjusted in-hospital mortality rate was lower or higher than the in-hospital mortality rate of the overall series, respectively. Propensity score matching yielded 1729 pairs of patients operated at over- or underperforming hospitals. Overperforming hospitals had a significantly lower in-hospital mortality (12.8% vs. 22.2%, p < 0.0001) along with decreased rate of stroke and/or global brain ischemia (16.5% vs. 19.9%, p = 0.009) compared to underperforming hospitals. Aggregate data meta-regression of the results of participating hospitals showed that hospital volume was inversely associated with in-hospital mortality (p = 0.043). Hospitals with an annual volume of less than 15 cases had an increased risk of in-hospital mortality (adjusted OR, 1.345, 95% CI 1.126-1.607). The present findings indicate that there are significant differences between hospitals in terms of early outcome after surgery for TAAD. Low hospital volume may be a determinant of poor outcome of TAAD. ClinicalTrials.gov Identifier: NCT04831073.

Identifiants

pubmed: 36826589
doi: 10.1007/s00068-023-02248-2
pii: 10.1007/s00068-023-02248-2
pmc: PMC10449993
doi:

Substances chimiques

1,3,4,6-tetra-O-acetyl-2-azido-2-deoxyglucopyranose 80321-89-7

Banques de données

ClinicalTrials.gov
['NCT04831073']

Types de publication

Observational Study Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1791-1801

Informations de copyright

© 2023. The Author(s).

Références

J Cardiothorac Surg. 2021 Jun 10;16(1):171
pubmed: 34112230
Gen Thorac Cardiovasc Surg. 2007 Dec;55(12):483-92
pubmed: 18066639
Eur J Prev Cardiol. 2018 Jun;25(1_suppl):3-14
pubmed: 29708034
Ann Thorac Surg. 2019 Nov;108(5):1299-1306
pubmed: 31400334
Surgery. 2020 Jul;168(1):185-192
pubmed: 32507629
Eur Heart J. 2021 Dec 28;43(1):44-52
pubmed: 34468733
Eur J Cardiothorac Surg. 2017 Dec 1;52(6):1104-1110
pubmed: 28977503
Eur J Vasc Endovasc Surg. 2021 Sep;62(3):388-398
pubmed: 34384687

Auteurs

Fausto Biancari (F)

Heart and Lung Center, Helsinki University Hospital, University of Helsinki, 00029, Helsinki, Finland. faustobiancari@yahoo.it.
Department of Medicine, South-Karelia Central Hospital, University of Helsinki, Lappeenranta, Finland. faustobiancari@yahoo.it.

Angelo M Dell'Aquila (AM)

Department of Cardiothoracic Surgery, University Hospital Muenster, Muenster, Germany.

Giuseppe Gatti (G)

Division of Cardiac Surgery, Cardio-Thoracic and Vascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.

Andrea Perrotti (A)

Department of Thoracic and Cardiovascular Surgery, University of Franche-Comte, Besancon, France.

Amélie Hervé (A)

Department of Thoracic and Cardiovascular Surgery, University of Franche-Comte, Besancon, France.

Joseph Touma (J)

Department of Vascular Surgery, Hôpitaux Universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris, Creteil, France.

Matteo Pettinari (M)

Department of Cardiac Surgery, Ziekenhuis Oost Limburg, Genk, Belgium.

Sven Peterss (S)

LMU University Hospital, Ludwig Maximilian University, Munich, Germany.

Joscha Buech (J)

LMU University Hospital, Ludwig Maximilian University, Munich, Germany.
German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany.

Konrad Wisniewski (K)

Department of Cardiothoracic Surgery, University Hospital Muenster, Muenster, Germany.

Tatu Juvonen (T)

Heart and Lung Center, Helsinki University Hospital, University of Helsinki, 00029, Helsinki, Finland.
Anesthesia and Critical Care, Research Unit of Surgery, University of Oulu, Oulu, Finland.

Mikko Jormalainen (M)

Heart and Lung Center, Helsinki University Hospital, University of Helsinki, 00029, Helsinki, Finland.

Caius Mustonen (C)

Heart and Lung Center, Helsinki University Hospital, University of Helsinki, 00029, Helsinki, Finland.

Andreas Rukosujew (A)

Department of Cardiothoracic Surgery, University Hospital Muenster, Muenster, Germany.

Till Demal (T)

Department of Cardiovascular Surgery, University Heart and Vascular Center Hamburg, Hamburg, Germany.

Lenard Conradi (L)

Department of Cardiovascular Surgery, University Heart and Vascular Center Hamburg, Hamburg, Germany.

Marek Pol (M)

Department of Cardiac Surgery, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic.

Petr Kacer (P)

Department of Cardiac Surgery, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic.

Francesco Onorati (F)

Division of Cardiac Surgery, University of Verona Medical School, Verona, Italy.

Cecilia Rossetti (C)

Division of Cardiac Surgery, University of Verona Medical School, Verona, Italy.

Igor Vendramin (I)

Cardiothoracic Department, University Hospital, Udine, Italy.

Daniela Piani (D)

Cardiothoracic Department, University Hospital, Udine, Italy.

Mauro Rinaldi (M)

Cardiac Surgery, Molinette Hospital, University of Turin, Turin, Italy.

Luisa Ferrante (L)

Cardiac Surgery, Molinette Hospital, University of Turin, Turin, Italy.

Eduard Quintana (E)

Department of Cardiovascular Surgery, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.

Robert Pruna-Guillen (R)

Department of Cardiovascular Surgery, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.

Javier Rodriguez Lega (JR)

Cardiovascular Surgery Department, University Hospital Gregorio Marañón, Madrid, Spain.

Angel G Pinto (AG)

Cardiovascular Surgery Department, University Hospital Gregorio Marañón, Madrid, Spain.

Metesh Acharya (M)

Department of Cardiac Surgery, Glenfield Hospital, Leicester, UK.

Zein El-Dean (Z)

Department of Cardiac Surgery, Glenfield Hospital, Leicester, UK.

Mark Field (M)

Liverpool Centre for Cardiovascular Sciences, Liverpool Heart and Chest Hospital, Liverpool, UK.

Amer Harky (A)

Liverpool Centre for Cardiovascular Sciences, Liverpool Heart and Chest Hospital, Liverpool, UK.

Manoj Kuduvalli (M)

Liverpool Centre for Cardiovascular Sciences, Liverpool Heart and Chest Hospital, Liverpool, UK.

Francesco Nappi (F)

Department of Cardiac Surgery, Centre Cardiologique du Nord de Saint-Denis, Paris, France.

Sebastien Gerelli (S)

Centre Hospitalier Annecy Genevois, Épagny-Metz-Tessy, France.

Dario Di Perna (D)

Centre Hospitalier Annecy Genevois, Épagny-Metz-Tessy, France.

Enzo Mazzaro (E)

Division of Cardiac Surgery, Cardio-Thoracic and Vascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.

Stefano Rosato (S)

Center for Global Health, National Health Institute, Rome, Italy.

Antonio Fiore (A)

Department of Cardiac Surgery, Hôpitaux Universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris, Creteil, France.

Giovanni Mariscalco (G)

Department of Cardiac Surgery, Glenfield Hospital, Leicester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH